U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.20%

Go back to U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.20%

McKesson (MCK) PT Lowered to $579 at Deutsche Bank

September 25, 2024 1:33 PM EDT

Deutsche Bank analyst George Hill lowered the price target on McKesson (NYSE: MCK) to $579.00 (from $623.00) while maintaining a Buy rating.

The analyst comments "MCK to Hold Investor Update Meeting Post FQ2:MCK recently announced its plan to report FQ2 earnings results on... More

William Blair Downgrades Global Payments (GPN) to Market Perform

September 25, 2024 6:59 AM EDT

William Blair analyst Andrew Jeffrey downgraded Global Payments (NYSE: GPN) from Outperform to Market Perform.

The analyst comments "More than a transition problem. We cut our rating to Market Perform from Outperform on the view that Globals merchant business faces structural competitive challenges impeding... More

Barclays Reiterates Overweight Rating on Visa (V)

September 25, 2024 6:29 AM EDT

Barclays analyst Ramsey El-Assal reiterated an Overweight rating and $319.00 price target on Visa (NYSE: V).

The analyst comments "Prior regulatory actions (such as Durbin) targeted specific technical practices or pricing levels, but the DoJ's new suit instead goes after underlying business strategies such as... More

RBC Capital Reiterates Outperform Rating on Global Payments (GPN)

September 25, 2024 6:22 AM EDT

RBC Capital analyst Daniel Perlin reiterated an Outperform rating and $158.00 price target on Global Payments (NYSE: GPN).

The analyst comments "FY25 preliminary guidance overshadows the many strategic initiatives offered during the Investor Day, specifically FY25 calls for MSD adj. revenue growth, which... More

Truist Securities Reiterates Buy Rating on Amgen (AMGN)

September 25, 2024 5:43 AM EDT

Truist Securities analyst Robyn Karnauskas reiterated a Buy rating and $320.00 price target on Amgen (NASDAQ: AMGN).

The analyst comments "Earlier this evening, Amgen (AMGN, Buy) provided positive Ph3 updates from two key pipeline programs - Uplizna in gMG and rocatinlimab in atopic... More

Goldman Sachs Reiterates Buy Rating on Global Payments (GPN)

September 25, 2024 5:40 AM EDT

Goldman Sachs analyst Will Nance reiterated a Buy rating and $132.00 price target on Global Payments (NYSE: GPN).

The analyst comments "We attended GPNs Investor Day where the company focused on 1) simplifying its operations by moving away from a holding company approach to running the business,... More

Global Payments (GPN) PT Lowered to $142 at Citi

September 25, 2024 5:31 AM EDT

Citi analyst Ashwin Shirvaikar lowered the price target on Global Payments (NYSE: GPN) to $142.00 (from $145.00) while maintaining a Buy rating.

The analyst comments "GPN checked several boxes at the analyst day, highlighted by organizational streamlining/strategy articulation, better disclosure, POS software opportunity,... More